Your institution may have access to this item. Find your institution then sign in to continue.
Title
Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
Authors
Haupt, E; Ledermann, H; Köpcke, W
Abstract
The aim of the study was to evaluate the efficacy of benfotiamine administered over three weeks (allithiamine; a lipid-soluble vitamin B1 prodrug with high bioavailability) to patients with diabetic polyneuropathy in a randomized, placebo-controlled, double-blind, two-center pilot study.
Publication
International journal of clinical pharmacology and therapeutics, 2005, Vol 43, Issue 2, p71